glp-1 receptor agonist drug names Evolution of GLP‐1 Agonists for Diabetes Treatment glp-1 receptor agonist drug names
Description
Beyond obesity: How weight loss drugs lowered heart disease, kidney and liver disease in 2024 trials Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025
Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial
Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Importantly, controlling inflammation is believed to contribute in the prevention of cardiovascular diseases (123)
doi: 10.1136/bmj.g7607 203 HardingJLShawJEPeetersACartensenBMaglianoDJ
